Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CAV1 |
| Upstream (Parents) |
|---|
| (<<) ADH1B → CAV1 |
| (<<) FABP4 → CAV1 |
| (<<) DCN → CAV1 |
| (<<) IGFBP7 → CAV1 |
| (<<) COL15A1 → CAV1 |
| (<<) VWF → CAV1 |
| Downstream (Children) |
|---|
| CAV1 → AKAP12 (>>) |
| CAV1 → AOC3 (>>) |
| CAV1 → ADH1B (>>) |
| CAV1 → HBB (>>) |
| CAV1 → LPL (>>) |
| CAV1 → MEOX2 (>>) |
| CAV1 → FOS (>>) |
| CAV1 → ITGA7 (>>) |
| CAV1 → FHL1 (>>) |
| CAV1 → DPT (>>) |
| CAV1 → ABCA8 (>>) |
| CAV1 → TIMP4 (>>) |
| CAV1 → SFRP1 (>>) |
| CAV1 → MT1M (>>) |
| CAV1 → PECAM1 (>>) |
| CAV1 → CFHR1///CFH (>>) |
| CAV1 → PPARG (>>) |
| CAV1 → CHRDL1 (>>) |
| CAV1 → ITM2A (>>) |
| CAV1 → G0S2 (>>) |
| CAV1 → ENPP2 (>>) |
| CAV1 → CES1 (>>) |
| CAV1 → EMCN (>>) |
| CAV1 → ID3 (>>) |
| CAV1 → ADAMTS1 (>>) |
| CAV1 → CFH (>>) |
| CAV1 → CLDN5 (>>) |
| CAV1 → ADH1C (>>) |
| CAV1 → PRELP (>>) |
| CAV1 → CAV2 (>>) |
| CAV1 → PROS1 (>>) |
| CAV1 → GREM2 (>>) |
| CAV1 → IGFBP7 (>>) |
| CAV1 → COL15A1 (>>) |
| CAV1 → ANXA1 (>>) |
| CAV1 → CDH5 (>>) |
| CAV1 → COX7A1 (>>) |
| CAV1 → AQP1 (>>) |
| CAV1 → GNG11 (>>) |
| CAV1 → HIGD1B (>>) |
| CAV1 → SPARCL1 (>>) |
| CAV1 → C10orf10 (>>) |
| CAV1 → LHFP (>>) |
| CAV1 → ID1 (>>) |
| CAV1 → GNAI1 (>>) |
| CAV1 → CD93 (>>) |
| CAV1 → EMP1 (>>) |
| CAV1 → AP4S1 (>>) |
| CAV1 → VWF (>>) |
| CAV1 → C13orf15 (>>) |
| CAV1 → PDE2A (>>) |
| CAV1 → PALMD (>>) |
| CAV1 → SIRPA (>>) |
| CAV1 → PSMB1 (>>) |
| CAV1 → CRYAB (>>) |
| CAV1 → ICAM2 (>>) |
| CAV1 → ITIH5 (>>) |
| CAV1 → LDHB (>>) |
| CAV1 → THBS4 (>>) |
| CAV1 → C14orf139 (>>) |
